A citation-based method for searching scientific literature

C Menin, E Bojnik, P Del Bianco, L Elefanti, K Gianesin, S Keppel, C Stagni, S Mocellin, A Vecchiato, A De Rossi. Br J Dermatol 2016
Times Cited: 6







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers.
E Rampazzo, R Bertorelle, L Serra, L Terrin, C Candiotto, S Pucciarelli, P Del Bianco, D Nitti, A De Rossi. Br J Cancer 2010
83
50

Premature aging and immune senescence in HIV-infected children.
Ketty Gianesin, Antoni Noguera-Julian, Marisa Zanchetta, Paola Del Bianco, Maria Raffaella Petrara, Riccardo Freguja, Osvalda Rampon, Clàudia Fortuny, Mireia Camós, Elena Mozzo,[...]. AIDS 2016
55
50

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
50

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, Hilda A Pickett, Howard C Shen, Chanel E Smart,[...]. Nat Genet 2013
383
33

The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Enrica Rampazzo, Paola Del Bianco, Roberta Bertorelle, Caterina Boso, Alessandro Perin, Giovanna Spiro, Francesca Bergamo, Claudio Belluco, Angela Buonadonna, Elisa Palazzari,[...]. Br J Cancer 2018
10
33

Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Paolo Boscolo-Rizzo, Enrica Rampazzo, Egle Perissinotto, Maria Assunta Piano, Silvia Giunco, Lorena Baboci, Giacomo Spinato, Roberto Spinato, Giancarlo Tirelli, Maria Cristina Da Mosto,[...]. Oral Oncol 2015
28
33

Reactivation of telomerase in cancer.
Semih Can Akincilar, Bilal Unal, Vinay Tergaonkar. Cell Mol Life Sci 2016
80
33

Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
Liliana Terrin, Enrica Rampazzo, Salvatore Pucciarelli, Marco Agostini, Roberta Bertorelle, Giovanni Esposito, Paola DelBianco, Donato Nitti, Anita De Rossi. Clin Cancer Res 2008
64
33

Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data.
J M Ruijter, C Ramakers, W M H Hoogaars, Y Karlen, O Bakker, M J B van den Hoff, A F M Moorman. Nucleic Acids Res 2009
33

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Paolo Boscolo-Rizzo, Maria Cristina Da Mosto, Enrica Rampazzo, Silvia Giunco, Annarosa Del Mistro, Anna Menegaldo, Lorena Baboci, Monica Mantovani, Giancarlo Tirelli, Anita De Rossi. Cancer Metastasis Rev 2016
28
33

The molecular landscape of head and neck cancer.
C René Leemans, Peter J F Snijders, Ruud H Brakenhoff. Nat Rev Cancer 2018
355
33

Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics.
Talal El-Hefnawy, Siva Raja, Lori Kelly, William L Bigbee, John M Kirkwood, James D Luketich, Tony E Godfrey. Clin Chem 2004
180
33

Optimization of extraction of circulating RNAs from plasma--enabling small RNA sequencing.
Melanie Spornraft, Benedikt Kirchner, Bettina Haase, Vladimir Benes, Michael W Pfaffl, Irmgard Riedmaier. PLoS One 2014
40
33

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
33

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
33

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
287
33

Classifying Melanoma by TERT Promoter Mutational Status.
Michael Shaughnessy, Ching-Ni Njauw, Mykyta Artomov, Hensin Tsao. J Invest Dermatol 2020
5
40

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
209
33

Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis.
Saverio Caini, Sara Raimondi, Harriet Johansson, Vincenzo De Giorgi, Ines Zanna, Domenico Palli, Sara Gandini. J Dermatol Sci 2015
24
16

The effect on melanoma risk of genes previously associated with telomere length.
Mark M Iles, D Timothy Bishop, John C Taylor, Nicholas K Hayward, Myriam Brossard, Anne E Cust, Alison M Dunning, Jeffrey E Lee, Eric K Moses, Lars A Akslen,[...]. J Natl Cancer Inst 2014
89
16

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
562
16

Shorter telomeres associate with a reduced risk of melanoma development.
Hongmei Nan, Mengmeng Du, Immaculata De Vivo, Joann E Manson, Simin Liu, Anne McTiernan, J David Curb, Lawrence S Lessin, Matthew R Bonner, Qun Guo,[...]. Cancer Res 2011
69
16

Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis.
Philip C Haycock, Emma E Heydon, Stephen Kaptoge, Adam S Butterworth, Alex Thompson, Peter Willeit. BMJ 2014
446
16

Telomere length and common disease: study design and analytical challenges.
Jennifer H Barrett, Mark M Iles, Alison M Dunning, Karen A Pooley. Hum Genet 2015
46
16

The association between telomere length and cancer risk in population studies.
Xun Zhu, Wei Han, Wenjie Xue, Yuxia Zou, Cuiwei Xie, Jiangbo Du, Guangfu Jin. Sci Rep 2016
76
16


Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status.
A L Frauchiger, J Mangana, M Rechsteiner, H Moch, B Seifert, R P Braun, R Dummer, S M Goldinger. Br J Dermatol 2016
17
16

Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
16

The role of BRAF mutations in primary melanoma growth rate and survival.
V J Mar, W Liu, B Devitt, S Q Wong, A Dobrovic, G A McArthur, R Wolfe, J W Kelly. Br J Dermatol 2015
26
16

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.
S Thurneysen, P F Cheng, H W Nagel, M Kunz, N Jaberg-Bentele, M Nägeli, M Ziegler, E Guenova, S M Goldinger, J Mangana,[...]. Br J Dermatol 2016
6
16

Mutational status of naevus-associated melanomas.
D Shitara, G Tell-Martí, C Badenas, M M S S Enokihara, L Alós, A B Larque, N Michalany, J A Puig-Butille, C Carrera, J Malvehy,[...]. Br J Dermatol 2015
22
16

From melanocytes to melanomas.
A Hunter Shain, Boris C Bastian. Nat Rev Cancer 2016
295
16

Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
C Mangas, M Potrony, C Mainetti, E Bianchi, P Carrozza Merlani, A Mancarella Eberhardt, E Maspoli-Postizzi, G Marazza, A Marcollo-Pini, F Pelloni,[...]. Br J Dermatol 2016
8
16


CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in vivo reflectance confocal microscopy.
F Beretti, P Manni, C Longo, G Argenziano, F Farnetani, A M Cesinaro, A M Witkowski, A De Pol, G Pellacani. Br J Dermatol 2015
12
16

The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
A T McConnell, R Ellis, B Pathy, R Plummer, P E Lovat, G O'Boyle. Br J Dermatol 2016
20
16

Melanoma and vitamin D.
Sinead Field, Julia A Newton-Bishop. Mol Oncol 2011
49
16

Characterization of patients at high risk of melanoma in Austria.
C Müller, J Wendt, S Rauscher, S Burgstaller-Muehlbacher, R Sunder-Plassmann, C Scheurecker, E Richtig, I Fae, G Fischer, H Pehamberger,[...]. Br J Dermatol 2016
7
16

Rewired ERK-JNK signaling pathways in melanoma.
Pablo Lopez-Bergami, Conway Huang, James S Goydos, Dana Yip, Menashe Bar-Eli, Meenhard Herlyn, Keiran S M Smalley, Alka Mahale, Alexey Eroshkin, Stuart Aaronson,[...]. Cancer Cell 2007
218
16


Prognostic factors for survival of patients treated systemically for disseminated melanoma.
O Eton, S S Legha, T E Moon, A C Buzaid, N E Papadopoulos, C Plager, A M Burgess, A Y Bedikian, S Ring, Q Dong,[...]. J Clin Oncol 1998
157
16

Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Laura S Burke, Paula L Hyland, Ruth M Pfeiffer, Jennifer Prescott, William Wheeler, Lisa Mirabello, Sharon A Savage, Laurie Burdette, Meredith Yeager, Stephen Chanock,[...]. PLoS One 2013
37
16

Resistant mechanisms to BRAF inhibitors in melanoma.
José Luís Manzano, Laura Layos, Cristina Bugés, María de Los Llanos Gil, Laia Vila, Eva Martínez-Balibrea, Anna Martínez-Cardús. Ann Transl Med 2016
117
16

Vitamin D, vitamin A, the primary melanoma transcriptome and survival.
S J O'Shea, J R Davies, J A Newton-Bishop. Br J Dermatol 2016
5
20

A stress-induced early innate response causes multidrug tolerance in melanoma.
D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, K Kashofer, K Wagner, G Zhang, E Bonyadi Rad,[...]. Oncogene 2015
33
16


Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
P Tschandl, A S Berghoff, M Preusser, J Pammer, H Pehamberger, H Kittler. Br J Dermatol 2016
9
16


A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Boudewijn J M Braakhuis, Maarten P Tabor, J Alain Kummer, C René Leemans, Ruud H Brakenhoff. Cancer Res 2003
835
16

Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis.
Serge J Smeets, Ruud H Brakenhoff, Bauke Ylstra, Wessel N van Wieringen, Mark A van de Wiel, C René Leemans, Boudewijn J M Braakhuis. Cell Oncol 2009
48
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.